YING YUAN to Retrospective Studies
This is a "connection" page, showing publications YING YUAN has written about Retrospective Studies.
Connection Strength
0.054
-
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab. J Neurooncol. 2024 Mar; 167(1):181-188.
Score: 0.012
-
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers. JCO Precis Oncol. 2022 02; 6:e2100267.
Score: 0.011
-
Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms. J Neurooncol. 2016 Feb; 126(3):527-33.
Score: 0.007
-
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr; 129(4):585-96.
Score: 0.007
-
Pregnancy and glial brain tumors. Neuro Oncol. 2014 Sep; 16(9):1289-94.
Score: 0.006
-
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis. J Neurooncol. 2013 Sep; 114(2):229-35.
Score: 0.006
-
[Influences of diagnostic modes on an early diagnosis of colorectal cancer]. Zhonghua Yi Xue Za Zhi. 2011 Nov 08; 91(41):2886-90.
Score: 0.005